Cadence raises $100 million to automate chronic disease care with regulated AI
Cadence, a digital health company specializing in chronic disease care, raised $100 million to expand its footprint and automate clinician work with artificial intelligence. The funding round reflects growing investment in AI-driven automation for healthcare delivery.
The Atomic take
Cadence's bet is that AI can take over the routine, repetitive parts of chronic care like medication adjustments and patient check-ins, freeing clinicians to handle cases that actually need human judgment. The "regulated" framing matters most here, because automating clinical work invites scrutiny from the FDA and malpractice questions that pure software companies rarely face. Watch whether Cadence publishes outcome data showing its automation matches or beats human clinicians, since that evidence is what will determine if payers and health systems trust it at scale.
Read the full story at STAT →Know where humanity is headed.
Five forces. One brief. Free, every Monday morning.
Get The Atomic Five